OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: Mystery of the Sphinx?
Zhaokai Zhou, Ge Zhang, Yudi Xu, et al.
Cancer Letters (2024) Vol. 597, pp. 217083-217083
Closed Access | Times Cited: 10
Zhaokai Zhou, Ge Zhang, Yudi Xu, et al.
Cancer Letters (2024) Vol. 597, pp. 217083-217083
Closed Access | Times Cited: 10
Showing 10 citing articles:
Multiple myeloma and anti-BCMA CAR-T therapy: a literature review
A. P. Faenko, Г. А. Дудина, C. K. Mabudzade
MD-Onco (2025) Vol. 4, Iss. 4, pp. 53-64
Closed Access
A. P. Faenko, Г. А. Дудина, C. K. Mabudzade
MD-Onco (2025) Vol. 4, Iss. 4, pp. 53-64
Closed Access
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
Fang Wang, Ruiqi Zhang, Zhaokai Zhou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Fang Wang, Ruiqi Zhang, Zhaokai Zhou, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products
Hammodah R. Alfar, Cecil Chen, Eric J. Lachacz, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hammodah R. Alfar, Cecil Chen, Eric J. Lachacz, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Defeating Cancer with Armed Antibodies and Genetically Modified Immune Cells
Liang Zhao
Highlights in Science Engineering and Technology (2025) Vol. 129, pp. 57-66
Closed Access
Liang Zhao
Highlights in Science Engineering and Technology (2025) Vol. 129, pp. 57-66
Closed Access
Characteristics of second primary malignancies following bispecific antibodies therapy
Xiaojie Liang, Baiwei Luo, B.Y. Lin, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011200-e011200
Open Access
Xiaojie Liang, Baiwei Luo, B.Y. Lin, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e011200-e011200
Open Access
Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Saber Imani, Reyhaneh Farghadani, Ghazaal Roozitalab, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR ‐NK Cell Engineering
Zhaokai Zhou, Yifeng Chen, Yuhao Ba, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
Zhaokai Zhou, Yifeng Chen, Yuhao Ba, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 1
Engraftment of a Surrogate Antigen Onto Tumor Cell Surface Via Phlip Peptide to Universally Target Car-T Cell Therapy to Solid Tumors
Xiaoliu Zhang, Yanting Zhang, Jane Jing Ting Lim, et al.
(2024)
Closed Access
Xiaoliu Zhang, Yanting Zhang, Jane Jing Ting Lim, et al.
(2024)
Closed Access
CYTOKINE RELEASE SYNDROME IN ONCOLOGIC PATIENTS TREATED WITH CAR-T
Michel Bolis
(2024), pp. 1541-1555
Open Access
Michel Bolis
(2024), pp. 1541-1555
Open Access
Engraftment of a Surrogate Antigen onto Tumor Cell Surface via pHLIP Peptide to Universally Target CAR-T Cell Therapy to Solid Tumors
Yanting Zhang, Xinping Fu, Jane Jing Ting Lim, et al.
Cancer Letters (2024) Vol. 608, pp. 217319-217319
Closed Access
Yanting Zhang, Xinping Fu, Jane Jing Ting Lim, et al.
Cancer Letters (2024) Vol. 608, pp. 217319-217319
Closed Access
